Global Prothrombin Time Testing Market
Global Prothrombin Time Testing Market

Prothrombin Time Testing Comprehensive Study by Type (Instruments, Consumables, Systems), Application (Thrombin Time (TT), Activated Partial Thromboplastin Time (APTT), Prothrombin Time (PT), Partial Thromboplastin Time (PTT), Others), Technology (Mechanical Technology, Electrochemical Technology, Optical Technology, Others), End-User (Diagnostic Laboratories, Hospitals, Clinical Laboratories, Home Care Settings, Others)

Prothrombin Time Testing Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jun 2021 Edition 248 Pages 217 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Prothrombin Time Testing Market Scope?
Prothrombin time (PT) is a blood test that is utilized to evaluate the time required to clot blood. This test is beneficial to detect and diagnose several bleeding and excessive clotting disorders and is also utilized to monitor the efficiency of numerous anticoagulants. Prothrombin time (PT) is a blood test that is used to assess the time required to clot blood. This test is useful to detect and diagnose various bleeding and excessive clotting disorder and monitor the efficacy of various anticoagulants. The major factors contributing to the Prothrombin time testing market's growth include the increasing prevalence of cardiovascular diseases in the geriatric population. Cardiovascular disease (CVD) and blood disorders are the leading cause of death in several countries.

The Prothrombin Time Testing market study is being classified by Type (Instruments, Consumables and Systems), by Application (Thrombin Time (TT), Activated Partial Thromboplastin Time (APTT), Prothrombin Time (PT), Partial Thromboplastin Time (PTT) and Others) and major geographies with country level break-up.

Owing to a rapidly rising geriatric population and rising demand for point of care testing is leading the global prothrombin time testing market on a higher trajectory. The upward sloping curve, charted by a significant CAGR (Compound Annual Growth Rate) will lead to a notable increase in market worth. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Prothrombin Time Testing market throughout the predicted period.

Sysmex Corporation (Japan), Medtronic (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (United States), Micropoint Biosciences (China), ARKRAY, Inc (Japan), NIHON KOHDEN CORPORATION (Japan), Diagnostica Stago S.A.S. (France), Thermo Fisher Scientific (United States), Helena Laboratories (United States), Siemens Healthcare GmbH (Germany), SEKISUI MEDICAL CO., LTD (Japan), Coagulation Sciences LLC (United States), Universal Biosensors (Australia), HemoSonics, LLC (United States) and Beckman Coulter, Inc (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Prothrombin Time Testing market by Type, Application and Region.

On the basis of geography, the market of Prothrombin Time Testing has been segmented into .

In 2019, ARKRAY, Inc. launched SPOTCHEM HS HS-7710, a blood coagulation testing product. It is faster and more efficient than other variants and allows for analysis, using whole blood samples, in surgical sites. Besides, it is automated. This is innovative and one of a kind in terms of blood analysis in surgeries. This demonstrates how product development and thus, research and development hold a crucial place in the market. and In 2018, Hoffman-La Roche Ltd launched CoaguChek Vantus. It is a home care setting coagulation testing system that is wireless and facilitates self-tests for patients. Mainly, it measures blood thinnersí effectiveness and sends data for analysis to healthcare providers.


Influencing Market Trend
  • The Increased Utilization of Point-Of-Care Testing (Poct) Products
  • High Efficiency of The Devices for Detecting the Blood Disorders

Market Drivers
  • The Growing of The Incidences of Cardiovascular Diseases
  • Increasing Of the Elderly Population

Opportunities
  • Increasing Research and Development Activities

Restraints
  • The Stringent Guidelines by Several Governing Authorities

Challenges
  • High Cost of The Testing
  • Lack Of Awareness


Key Target Audience
Providers of Prothrombin Time Testing, Governmental and Regulatory bodies and End-Users

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Frequently Asked Questions (FAQ):

1. At what growth rate would the Prothrombin Time Testing market expands?
The Global Prothrombin Time Testing market is expected to see a growth of % during projected year 2020 to 2026.

2. Who are the prominent players of the Global Prothrombin Time Testing market?
The prominent players of Global Prothrombin Time Testing market are Sysmex Corporation (Japan), Medtronic (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (United States), Micropoint Biosciences (China), ARKRAY, Inc (Japan), NIHON KOHDEN CORPORATION (Japan), Diagnostica Stago S.A.S. (France), Thermo Fisher Scientific (United States), Helena Laboratories (United States), Siemens Healthcare GmbH (Germany), SEKISUI MEDICAL CO., LTD (Japan), Coagulation Sciences LLC (United States), Universal Biosensors (Australia), HemoSonics, LLC (United States) and Beckman Coulter, Inc (United States), to name a few.

3. What are the top priorities to focus for Prothrombin Time Testing marketís growth?
In this highly competitive & fast evolving Prothrombin Time Testing industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.
Report Objectives / Segmentation Covered
By Type
  • Instruments
  • Consumables
  • Systems
By Application
  • Thrombin Time (TT)
  • Activated Partial Thromboplastin Time (APTT)
  • Prothrombin Time (PT)
  • Partial Thromboplastin Time (PTT)
  • Others
By Technology
  • Mechanical Technology
  • Electrochemical Technology
  • Optical Technology
  • Others

By End-User
  • Diagnostic Laboratories
  • Hospitals
  • Clinical Laboratories
  • Home Care Settings
  • Others

By Regions
    • 1. Market Overview
      • 1.1. Introduction
      • 1.2. Scope/Objective of the Study
        • 1.2.1. Research Objective
    • 2. Executive Summary
      • 2.1. Introduction
    • 3. Market Dynamics
      • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. The Growing of The Incidences of Cardiovascular Diseases
        • 3.2.2. Increasing Of the Elderly Population
      • 3.3. Market Challenges
        • 3.3.1. High Cost of The Testing
        • 3.3.2. Lack Of Awareness
      • 3.4. Market Trends
        • 3.4.1. The Increased Utilization of Point-Of-Care Testing (Poct) Products
        • 3.4.2. High Efficiency of The Devices for Detecting the Blood Disorders
    • 4. Market Factor Analysis
      • 4.1. Porters Five Forces
      • 4.2. Supply/Value Chain
      • 4.3. PESTEL analysis
      • 4.4. Market Entropy
      • 4.5. Patent/Trademark Analysis
    • 5. Global Prothrombin Time Testing, by Type, Application, Technology and End-User (value and price ) (2015-2020)
      • 5.1. Introduction
      • 5.2. Global Prothrombin Time Testing (Value)
        • 5.2.1. Global Prothrombin Time Testing by: Type (Value)
          • 5.2.1.1. Instruments
          • 5.2.1.2. Consumables
          • 5.2.1.3. Systems
        • 5.2.2. Global Prothrombin Time Testing by: Application (Value)
          • 5.2.2.1. Thrombin Time (TT)
          • 5.2.2.2. Activated Partial Thromboplastin Time (APTT)
          • 5.2.2.3. Prothrombin Time (PT)
          • 5.2.2.4. Partial Thromboplastin Time (PTT)
          • 5.2.2.5. Others
        • 5.2.3. Global Prothrombin Time Testing by: Technology (Value)
          • 5.2.3.1. Mechanical Technology
          • 5.2.3.2. Electrochemical Technology
          • 5.2.3.3. Optical Technology
          • 5.2.3.4. Others
        • 5.2.4. Global Prothrombin Time Testing by: End-User (Value)
          • 5.2.4.1. Diagnostic Laboratories
          • 5.2.4.2. Hospitals
          • 5.2.4.3. Clinical Laboratories
          • 5.2.4.4. Home Care Settings
          • 5.2.4.5. Others
      • 5.3. Global Prothrombin Time Testing (Price)
        • 5.3.1. Global Prothrombin Time Testing by: Type (Price)
    • 6. Prothrombin Time Testing: Manufacturers/Players Analysis
      • 6.1. Competitive Landscape
        • 6.1.1. Market Share Analysis
          • 6.1.1.1. Top 3
          • 6.1.1.2. Top 5
      • 6.2. Peer Group Analysis (2020)
      • 6.3. BCG Matrix
      • 6.4. Company Profile
        • 6.4.1. Sysmex Corporation (Japan)
          • 6.4.1.1. Business Overview
          • 6.4.1.2. Products/Services Offerings
          • 6.4.1.3. Financial Analysis
          • 6.4.1.4. SWOT Analysis
        • 6.4.2. Medtronic (Ireland)
          • 6.4.2.1. Business Overview
          • 6.4.2.2. Products/Services Offerings
          • 6.4.2.3. Financial Analysis
          • 6.4.2.4. SWOT Analysis
        • 6.4.3. F. Hoffmann-La Roche Ltd (Switzerland)
          • 6.4.3.1. Business Overview
          • 6.4.3.2. Products/Services Offerings
          • 6.4.3.3. Financial Analysis
          • 6.4.3.4. SWOT Analysis
        • 6.4.4. Abbott (United States)
          • 6.4.4.1. Business Overview
          • 6.4.4.2. Products/Services Offerings
          • 6.4.4.3. Financial Analysis
          • 6.4.4.4. SWOT Analysis
        • 6.4.5. Micropoint Biosciences (China)
          • 6.4.5.1. Business Overview
          • 6.4.5.2. Products/Services Offerings
          • 6.4.5.3. Financial Analysis
          • 6.4.5.4. SWOT Analysis
        • 6.4.6. ARKRAY, Inc (Japan)
          • 6.4.6.1. Business Overview
          • 6.4.6.2. Products/Services Offerings
          • 6.4.6.3. Financial Analysis
          • 6.4.6.4. SWOT Analysis
        • 6.4.7. NIHON KOHDEN CORPORATION (Japan)
          • 6.4.7.1. Business Overview
          • 6.4.7.2. Products/Services Offerings
          • 6.4.7.3. Financial Analysis
          • 6.4.7.4. SWOT Analysis
        • 6.4.8. Diagnostica Stago S.A.S. (France)
          • 6.4.8.1. Business Overview
          • 6.4.8.2. Products/Services Offerings
          • 6.4.8.3. Financial Analysis
          • 6.4.8.4. SWOT Analysis
        • 6.4.9. Thermo Fisher Scientific (United States)
          • 6.4.9.1. Business Overview
          • 6.4.9.2. Products/Services Offerings
          • 6.4.9.3. Financial Analysis
          • 6.4.9.4. SWOT Analysis
        • 6.4.10. Helena Laboratories (United States)
          • 6.4.10.1. Business Overview
          • 6.4.10.2. Products/Services Offerings
          • 6.4.10.3. Financial Analysis
          • 6.4.10.4. SWOT Analysis
        • 6.4.11. Siemens Healthcare GmbH (Germany)
          • 6.4.11.1. Business Overview
          • 6.4.11.2. Products/Services Offerings
          • 6.4.11.3. Financial Analysis
          • 6.4.11.4. SWOT Analysis
        • 6.4.12. SEKISUI MEDICAL CO., LTD (Japan)
          • 6.4.12.1. Business Overview
          • 6.4.12.2. Products/Services Offerings
          • 6.4.12.3. Financial Analysis
          • 6.4.12.4. SWOT Analysis
        • 6.4.13. Coagulation Sciences LLC (United States)
          • 6.4.13.1. Business Overview
          • 6.4.13.2. Products/Services Offerings
          • 6.4.13.3. Financial Analysis
          • 6.4.13.4. SWOT Analysis
        • 6.4.14. Universal Biosensors (Australia)
          • 6.4.14.1. Business Overview
          • 6.4.14.2. Products/Services Offerings
          • 6.4.14.3. Financial Analysis
          • 6.4.14.4. SWOT Analysis
        • 6.4.15. HemoSonics, LLC (United States)
          • 6.4.15.1. Business Overview
          • 6.4.15.2. Products/Services Offerings
          • 6.4.15.3. Financial Analysis
          • 6.4.15.4. SWOT Analysis
        • 6.4.16. Beckman Coulter, Inc (United States)
          • 6.4.16.1. Business Overview
          • 6.4.16.2. Products/Services Offerings
          • 6.4.16.3. Financial Analysis
          • 6.4.16.4. SWOT Analysis
    • 7. Global Prothrombin Time Testing Sale, by Type, Application, Technology and End-User (value and price ) (2021-2026)
      • 7.1. Introduction
      • 7.2. Global Prothrombin Time Testing (Value)
        • 7.2.1. Global Prothrombin Time Testing by: Type (Value)
          • 7.2.1.1. Instruments
          • 7.2.1.2. Consumables
          • 7.2.1.3. Systems
        • 7.2.2. Global Prothrombin Time Testing by: Application (Value)
          • 7.2.2.1. Thrombin Time (TT)
          • 7.2.2.2. Activated Partial Thromboplastin Time (APTT)
          • 7.2.2.3. Prothrombin Time (PT)
          • 7.2.2.4. Partial Thromboplastin Time (PTT)
          • 7.2.2.5. Others
        • 7.2.3. Global Prothrombin Time Testing by: Technology (Value)
          • 7.2.3.1. Mechanical Technology
          • 7.2.3.2. Electrochemical Technology
          • 7.2.3.3. Optical Technology
          • 7.2.3.4. Others
        • 7.2.4. Global Prothrombin Time Testing by: End-User (Value)
          • 7.2.4.1. Diagnostic Laboratories
          • 7.2.4.2. Hospitals
          • 7.2.4.3. Clinical Laboratories
          • 7.2.4.4. Home Care Settings
          • 7.2.4.5. Others
      • 7.3. Global Prothrombin Time Testing (Price)
        • 7.3.1. Global Prothrombin Time Testing by: Type (Price)
    • 8. Appendix
      • 8.1. Acronyms
    • 9. Methodology and Data Source
      • 9.1. Methodology/Research Approach
        • 9.1.1. Research Programs/Design
        • 9.1.2. Market Size Estimation
        • 9.1.3. Market Breakdown and Data Triangulation
      • 9.2. Data Source
        • 9.2.1. Secondary Sources
        • 9.2.2. Primary Sources
      • 9.3. Disclaimer
    List of Tables
    • Table 1. Prothrombin Time Testing: by Type(USD Million)
    • Table 2. Prothrombin Time Testing: by Application(USD Million)
    • Table 3. Prothrombin Time Testing: by Technology(USD Million)
    • Table 4. Prothrombin Time Testing: by End-User(USD Million)
    • Table 5. Prothrombin Time Testing: by Type(USD/Units)
    • Table 6. Company Basic Information, Sales Area and Its Competitors
    • Table 7. Company Basic Information, Sales Area and Its Competitors
    • Table 8. Company Basic Information, Sales Area and Its Competitors
    • Table 9. Company Basic Information, Sales Area and Its Competitors
    • Table 10. Company Basic Information, Sales Area and Its Competitors
    • Table 11. Company Basic Information, Sales Area and Its Competitors
    • Table 12. Company Basic Information, Sales Area and Its Competitors
    • Table 13. Company Basic Information, Sales Area and Its Competitors
    • Table 14. Company Basic Information, Sales Area and Its Competitors
    • Table 15. Company Basic Information, Sales Area and Its Competitors
    • Table 16. Company Basic Information, Sales Area and Its Competitors
    • Table 17. Company Basic Information, Sales Area and Its Competitors
    • Table 18. Company Basic Information, Sales Area and Its Competitors
    • Table 19. Company Basic Information, Sales Area and Its Competitors
    • Table 20. Company Basic Information, Sales Area and Its Competitors
    • Table 21. Company Basic Information, Sales Area and Its Competitors
    • Table 22. Prothrombin Time Testing: by Type(USD Million)
    • Table 23. Prothrombin Time Testing: by Application(USD Million)
    • Table 24. Prothrombin Time Testing: by Technology(USD Million)
    • Table 25. Prothrombin Time Testing: by End-User(USD Million)
    • Table 26. Prothrombin Time Testing: by Type(USD/Units)
    • Table 27. Research Programs/Design for This Report
    • Table 28. Key Data Information from Secondary Sources
    • Table 29. Key Data Information from Primary Sources
    List of Figures
    • Figure 1. Porters Five Forces
    • Figure 2. Supply/Value Chain
    • Figure 3. PESTEL analysis
    • Figure 4. Global Prothrombin Time Testing: by Type USD Million (2015-2020)
    • Figure 5. Global Prothrombin Time Testing: by Application USD Million (2015-2020)
    • Figure 6. Global Prothrombin Time Testing: by Technology USD Million (2015-2020)
    • Figure 7. Global Prothrombin Time Testing: by End-User USD Million (2015-2020)
    • Figure 8. Global Prothrombin Time Testing: by Type USD/Units (2015-2020)
    • Figure 9. Global Prothrombin Time Testing share by Players 2020 (%)
    • Figure 10. Global Prothrombin Time Testing share by Players (Top 3) 2020(%)
    • Figure 11. Global Prothrombin Time Testing share by Players (Top 5) 2020(%)
    • Figure 12. BCG Matrix for key Companies
    • Figure 13. Sysmex Corporation (Japan) Revenue, Net Income and Gross profit
    • Figure 14. Sysmex Corporation (Japan) Revenue: by Geography 2020
    • Figure 15. Medtronic (Ireland) Revenue, Net Income and Gross profit
    • Figure 16. Medtronic (Ireland) Revenue: by Geography 2020
    • Figure 17. F. Hoffmann-La Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
    • Figure 18. F. Hoffmann-La Roche Ltd (Switzerland) Revenue: by Geography 2020
    • Figure 19. Abbott (United States) Revenue, Net Income and Gross profit
    • Figure 20. Abbott (United States) Revenue: by Geography 2020
    • Figure 21. Micropoint Biosciences (China) Revenue, Net Income and Gross profit
    • Figure 22. Micropoint Biosciences (China) Revenue: by Geography 2020
    • Figure 23. ARKRAY, Inc (Japan) Revenue, Net Income and Gross profit
    • Figure 24. ARKRAY, Inc (Japan) Revenue: by Geography 2020
    • Figure 25. NIHON KOHDEN CORPORATION (Japan) Revenue, Net Income and Gross profit
    • Figure 26. NIHON KOHDEN CORPORATION (Japan) Revenue: by Geography 2020
    • Figure 27. Diagnostica Stago S.A.S. (France) Revenue, Net Income and Gross profit
    • Figure 28. Diagnostica Stago S.A.S. (France) Revenue: by Geography 2020
    • Figure 29. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
    • Figure 30. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
    • Figure 31. Helena Laboratories (United States) Revenue, Net Income and Gross profit
    • Figure 32. Helena Laboratories (United States) Revenue: by Geography 2020
    • Figure 33. Siemens Healthcare GmbH (Germany) Revenue, Net Income and Gross profit
    • Figure 34. Siemens Healthcare GmbH (Germany) Revenue: by Geography 2020
    • Figure 35. SEKISUI MEDICAL CO., LTD (Japan) Revenue, Net Income and Gross profit
    • Figure 36. SEKISUI MEDICAL CO., LTD (Japan) Revenue: by Geography 2020
    • Figure 37. Coagulation Sciences LLC (United States) Revenue, Net Income and Gross profit
    • Figure 38. Coagulation Sciences LLC (United States) Revenue: by Geography 2020
    • Figure 39. Universal Biosensors (Australia) Revenue, Net Income and Gross profit
    • Figure 40. Universal Biosensors (Australia) Revenue: by Geography 2020
    • Figure 41. HemoSonics, LLC (United States) Revenue, Net Income and Gross profit
    • Figure 42. HemoSonics, LLC (United States) Revenue: by Geography 2020
    • Figure 43. Beckman Coulter, Inc (United States) Revenue, Net Income and Gross profit
    • Figure 44. Beckman Coulter, Inc (United States) Revenue: by Geography 2020
    • Figure 45. Global Prothrombin Time Testing: by Type USD Million (2021-2026)
    • Figure 46. Global Prothrombin Time Testing: by Application USD Million (2021-2026)
    • Figure 47. Global Prothrombin Time Testing: by Technology USD Million (2021-2026)
    • Figure 48. Global Prothrombin Time Testing: by End-User USD Million (2021-2026)
    • Figure 49. Global Prothrombin Time Testing: by Type USD/Units (2021-2026)
    Some of the key companies/manufacturers profiled in the report
    • Sysmex Corporation (Japan)
    • Medtronic (Ireland)
    • F. Hoffmann-La Roche Ltd (Switzerland)
    • Abbott (United States)
    • Micropoint Biosciences (China)
    • ARKRAY, Inc (Japan)
    • NIHON KOHDEN CORPORATION (Japan)
    • Diagnostica Stago S.A.S. (France)
    • Thermo Fisher Scientific (United States)
    • Helena Laboratories (United States)
    • Siemens Healthcare GmbH (Germany)
    • SEKISUI MEDICAL CO., LTD (Japan)
    • Coagulation Sciences LLC (United States)
    • Universal Biosensors (Australia)
    • HemoSonics, LLC (United States)
    • Beckman Coulter, Inc (United States)
    Select License Type
    Sample Report Enquiry Before Buy Request Discount

    Speak with Analyst

    Want to find out more about this report?

    Get Free Consultation